Renaissance Technologies’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-23,300
| Closed | -$99K | – | 4353 |
|
|
2022
Q4 | $99K | Buy |
+23,300
| New | +$99K | ﹤0.01% | 3622 |
|
|
2022
Q3 | – | Sell |
-49,118
| Closed | -$49K | – | 4371 |
|
|
2022
Q2 | $49K | Buy |
+49,118
| New | +$49K | ﹤0.01% | 4000 |
|
|
2021
Q3 | – | Sell |
-125,452
| Closed | -$936K | – | 3811 |
|
|
2021
Q2 | $936K | Buy |
125,452
+56,840
| +83% | +$424K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $403K | Sell |
68,612
-184,600
| -73% | -$1.08M | ﹤0.01% | 2987 |
|
|
2020
Q4 | $1.19M | Sell |
253,212
-50,200
| -17% | -$236K | ﹤0.01% | 2417 |
|
|
2020
Q3 | $1.04M | Sell |
303,412
-57,700
| -16% | -$199K | ﹤0.01% | 2497 |
|
|
2020
Q2 | $1.07M | Buy |
361,112
+191,813
| +113% | +$570K | ﹤0.01% | 2505 |
|
|
2020
Q1 | $401K | Sell |
169,299
-20,535
| -11% | -$48.6K | ﹤0.01% | 2863 |
|
|
2019
Q4 | $304K | Buy |
189,834
+77,728
| +69% | +$124K | ﹤0.01% | 3068 |
|
|
2019
Q3 | $201K | Buy |
112,106
+27,576
| +33% | +$49.4K | ﹤0.01% | 3145 |
|
|
2019
Q2 | $107K | Buy |
84,530
+8,200
| +11% | +$10.4K | ﹤0.01% | 3388 |
|
|
2019
Q1 | $140K | Buy |
76,330
+27,230
| +55% | +$49.9K | ﹤0.01% | 3259 |
|
|
2018
Q4 | $56K | Buy |
49,100
+10,400
| +27% | +$11.9K | ﹤0.01% | 3285 |
|
|
2018
Q3 | $86K | Sell |
38,700
-71,100
| -65% | -$158K | ﹤0.01% | 3252 |
|
|
2018
Q2 | $269K | Sell |
109,800
-55,800
| -34% | -$137K | ﹤0.01% | 3001 |
|
|
2018
Q1 | $2.14M | Buy |
165,600
+49,000
| +42% | +$632K | ﹤0.01% | 2299 |
|
|
2017
Q4 | $1.29M | Buy |
116,600
+15,600
| +15% | +$173K | ﹤0.01% | 2566 |
|
|
2017
Q3 | $1.27M | Buy |
101,000
+62,500
| +162% | +$785K | ﹤0.01% | 2487 |
|
|
2017
Q2 | $439K | Buy |
38,500
+18,398
| +92% | +$210K | ﹤0.01% | 2797 |
|
|
2017
Q1 | $267K | Buy |
+20,102
| New | +$267K | ﹤0.01% | 2939 |
|